ELAN Elanco Animal Health

Elanco posted Q2 sales of $1.24 billion, beating estimates and growing 5% YoY; adjusted EPS was $0.26, down 13% YoY. Pet Health revenue rose 11% to $643 million; Seresto and Advantage lines contributed $113 million and $147 million, respectively.

U.S. stocks were mixed, with the Dow Jones index falling around 200 points on Thursday. Shares of Applovin Corp APP rose sharply during Thursday's session following upbeat earnings. AppLovin reported second-quarter revenue of $1.26 billion, missing analyst estimates of $1.31 billion, according ...

Elanco Animal Health (ELAN) delivered earnings and revenue surprises of +30.00% and +4.67%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Elanco Animal Health ( NYSE:ELAN ) , a global animal health company providing products and services for pets and livestock, reported its second quarter 2025 earnings on August 7, 2025. The most notable news was a strong revenue beat and solid performance in its innovation portfolio, especially ...

U.S. Physical Therapy (USPH) delivered earnings and revenue surprises of +14.08% and +3.78%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Looking beyond Wall Street's top-and-bottom-line estimate forecasts for Elanco Animal Health (ELAN), delve into some of its key metrics to gain a deeper insight into the company's potential performance for the quarter ended June 2025.